Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control
NCT ID: NCT00463632
Last Updated: 2010-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2007-01-31
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso
NCT00463528
Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso
NCT06973200
Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes
NCT00463593
Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana
NCT00463931
Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal
NCT01553552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific objectives are:
* to determine the prevalence and intensity of schistosome infection in pregnant women attending for antenatal care and in non-pregnant women of reproductive age in an area which is hyperendemic for S.haematobium infection and in which there is little or no S.mansoni infection
* to determine the prevalence and intensity of schistosome infection in pregnant women attending for antenatal care and in non-pregnant women of reproductive age in an area in which S.mansoni infection is common
* to determine Haemoglobin concentration in pregnant women attending for antenatal care and in non-pregnant women of reproductive age in the regions described above
* to investigate the association between infection and haemoglobin concentration in pregnant and non-pregnant women
* to determine the prevalence of other parasitic infections in pregnant women and non-pregnant women including hookworms, ascaris, trichuris and malaria
* to demonstrate the research team's ability to follow-up pregnant women recruited at antenatal care clinics onto the postpartum period
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-pregnant women age 15-45 years accompanying relatives or children to the health centres or for immunization
15 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Muraz
OTHER
DBL -Institute for Health Research and Development
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seydou Touré, MD
Role: PRINCIPAL_INVESTIGATOR
The National Schistosomiasis Control Program Burkina Faso
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dori Health Centre
Dori, , Burkina Faso
National Schistosomiasis Control Program
Ouagadougou, , Burkina Faso
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SRP-BF-ST-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.